Market Overview

Jim Cramer Gives His Opinion On Allergan, USG And Arena Pharmaceuticals

Related AGN
Cantor Fitzgerald Makes An Uber-Bullish Call On Galmed Pharmaceuticals
The IPO Outlook For The Week Of June 18: Pharma, Pharma And More Pharma
Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow (Seeking Alpha)
Related USG
Benzinga's Top Upgrades, Downgrades For June 12, 2018
Homebuilders And Housing: Spring Selling Season Is Starting Up

On CNBC's "Mad Money Lightning Round", Jim Cramer said Allergan plc (NYSE: AGN) is an inexpensive stock and he would buy it. He explained that the stock is struggling at the moment, because the company has a drug that might come off patent.

Cramer would wait for USG Corporation (NYSE: USG) to come down. He would buy it after it pulls back.

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) has reinvented itself and now the stock is undervalued, thinks Cramer. He believes the stock is good.

Posted-In: CNBC mad money Lightning Round Jim CramerMedia


Related Articles (ARNA + AGN)

View Comments and Join the Discussion!